Oncology in China

Peking University First Hospital has a total capacity of 1,805 beds across three campuses: Central, Miyun, and Daxing. The hospital delivers a full range of inpatient and outpatient services, serving patients across China and internationally.

Established in 1915, Peking University First Hospital (PUFH) is one of China's most prestigious medical institutions, affiliated with the Peking University Health Science Center. As a top-tier tertiary hospital classified as Grade 3A, it is recognized for its leadership in clinical excellence, education, and research. Over the decades, PUFH has been pioneering in shaping modern Chinese medicine, particularly in specialties such as urology, nephrology, pediatrics, neurology, cardiology, and organ transplantation.

The hospital is home to a team of highly qualified doctors and professors, including many national-level experts. Known for managing complex and rare diseases, it continues to advance patient care through innovation, multidisciplinary collaboration, and compassionate treatment.

Advanced Technology & Facilities

• Modern Medical Infrastructure – Equipped with advanced diagnostic imaging systems, robotic surgery platforms, and interventional radiology tools to support precise, minimally invasive treatments.
   
• Dedicated Medical Campuses – Three specialized campuses support diverse healthcare needs: Central Campus for core clinical care, Miyun for community health, and the new Daxing Campus for advanced pediatrics, emergency care, and translational research.
   
• High-Tech Labs & Research Centers – State-of-the-art laboratories for molecular biology, precision medicine, and regenerative therapies support ongoing clinical and academic innovation.
  
   

Key Services at Peking University First Hospital

• National Specialty Leader – Home to 12 national key medical disciplines and 18 top clinical specialties, including nephrology, urology, cardiology, OB-GYN, and pediatric neurology.
   
• Expert Surgical Care – Specializes in complex surgeries such as kidney and lung transplants, cardiovascular interventions, thoracoscopic and laparoscopic procedures.
   
• Integrated Teaching & Research – As a teaching hospital of Peking University, it trains thousands of medical students and professionals while conducting large-scale clinical research and publishing in top global journals.

Peking University First Hospital blends a century of medical heritage with high-quality clinical care, innovative research, and comprehensive education. It stands as a benchmark of excellence in China, committed to improving patient outcomes through multidisciplinary collaboration and compassionate, personalized care.

The hospital has approximately 50 inpatient beds in its main campus, along with nine satellite clinics across Beijing. It manages over 2,500 outpatient visits each week and provides care to hundreds of thousands of patients annually, both local and international.

Beijing United Family Hospital (BJU) is one of China’s most prestigious private medical institutions, known for delivering world-class healthcare that meets international standards. Established in 1997, it was the first foreign-invested hospital in China and has since become a trusted choice for both International and Chinese patients seeking high-quality, patient-focused care. As part of the United Family Healthcare network, BJU has built a reputation for medical excellence, advanced technology, and a uniquely personalized approach to treatment.

The hospital is staffed by a diverse team of internationally trained doctors, many of whom have practiced in top healthcare systems across the U.S., Europe, and Asia. This global expertise is complemented by the latest medical equipment, multilingual support services, and a strong commitment to clinical safety and patient satisfaction. Recognized by the Joint Commission International (JCI) for meeting the highest standards in healthcare delivery, BJU offers a full spectrum of medical services across numerous specialties, including family medicine, internal medicine, orthopedics, oncology, cardiology, obstetrics, pediatrics, and plastic surgery.

Advanced Technology & Facilities

• Modern Equipment: Advanced imaging—MRI, CT, Siemens X‑ray, mammography systems—as well as robotic‑assisted (da Vinci) and minimally invasive surgery, catheter labs, and full 24‑hour ICU and Emergency Department.
• Specialized Departments: Includes Family Medicine, Cardiology, Oncology, Pediatrics (with a child‑friendly environment since 2014), Orthopedics, Neurology, OB‑GYN, Dental, Dermatology, Pain Management, Integrative Medicine, Physical Therapy, and Cosmetic Surgery.
• Information Systems: Accredited EMRAM Stage 6, CAP certified, with hospital-wide electronic medical record sharing and direct billing agreements with top international insurers (BUPA, Aetna, Cigna, International SOS, etc.).

Key Services at BJU

• Comprehensive Multidisciplinary Care: From prenatal and obstetric services—including Western‑style birthing—to chronic disease treatment and advanced cancer therapies.
• Emergency & ICU: Fully staffed, 24/7 emergency and intensive care units with internationally-trained doctors and English-speaking teams
• Surgical Innovation: Robotics and minimally invasive techniques in cardiovascular, neurosurgery, orthopedic, and general surgery procedures.
• Patient-Centered & International Service: Highly rated for empathetic care, longer consultation times, language support in over a dozen languages, and 24‑hour translation services.

Beijing United Family Hospital stands as a pioneer in international-standard healthcare in China, blending modern technology, world-class medical expertise, and a warm, comprehensive approach to family health.

As part of Singapore‑listed Raffles Medical Group, founded in 1976, RMG China operates 5 tertiary hospitals and over 100 clinics, supported by 430+ physicians and 900+ nurses & allied health professionals, delivering comprehensive inpatient and outpatient services.

Raffles Medical Group has operated in China since 2010, growing into a trusted name among both local and expatriate communities. All RMG China hospitals and clinics follow the Group’s Institutional Group Practice Model, which emphasizes integrated, peer-reviewed, and clinically audited care. Backed by Raffles Hospital Singapore, accredited by Joint Commission International (JCI), the network ensures alignment with global standards for quality and patient safety. With a rigorous clinical governance framework, strategic insurance and corporate partnerships, and a presence in key Chinese cities, RMG serves over 2.8 million patients annually. The Group continues to expand across China, offering world-class healthcare that combines international expertise with localized, patient-centered care.

Advanced Technology & Facilities

• State-of-the-Art Equipment – China facilities include 24-hour emergency units, advanced diagnostic imaging and laboratories, and day-surgery theatres, delivering quality on par with international private hospitals.
• Specialized Medical Units – Services span family medicine, specialist outpatient care (e.g., dentistry, orthopedics), obstetrics & gynecology, pediatrics, rehabilitation, vaccination, and house calls, ensuring a holistic care continuum.
• Comfortable Patient Care – Amenities include modern inpatient wards, multilingual staff, streamlined online appointment systems, corporate health services, and dedicated hotlines to enhance patient experience and accessibility.

Key Services at Raffles Medical Group China

• Comprehensive Medical Care – Offering preventive health screenings, family and specialist consultations, emergency care, diagnostics, outpatient procedures, maternity, and rehabilitation.
• Corporate & Expatriate Healthcare – Designs bespoke employee health packages and occupational medicine; supports expatriates through internationally aligned clinical services.
• Institutional Excellence & Clinical Governance – Care is grounded in the Group Practice Model, featuring peer review, audits, and alignment with Singapore’s JCI-accredited Raffles Hospital standards
• Strategic Expansion & Innovation – China operations began in 2010; major milestones include Raffles Hospital Chongqing (2019), Beijing (2021), and Shanghai (July 2021). Plans are underway to continue expanding across China

Raffles Medical Group China is a leading integrated private hospital network, delivering high-quality, multidisciplinary medical care in major Chinese cities. With its robust institutional infrastructure, advanced diagnostic and treatment facilities, and a reputation anchored by the Singapore-based Raffles Hospital, RMG China continues to expand and uphold global healthcare standards.

GoBroad Healthcare Group, founded in 2017, is a leading medical network in China, specializing in the treatment of complex hematologic diseases and solid tumors. The group integrates clinical treatment, research, reference laboratories, and medical information technology under an Academic Research Organization model. With seven hospitals across Beijing, Shanghai, and Guangzhou, it provides advanced therapies including CAR-T cell therapy, hematopoietic stem cell transplantation, chemotherapy, radiotherapy, and targeted therapy. Its multidisciplinary teams ensure that patients receive comprehensive and personalized treatment for both common and rare conditions. The group is known for its patient-centered approach by combining modern medical science with innovative therapies and long-term follow-up care. With international collaborations, multilingual staff, and dedicated global patient services, it has become a trusted choice for individuals seeking specialized cancer and hematology treatments in China. By focusing on research-driven medicine, advanced facilities, and supportive care, GoBroad Healthcare Group continues to enhance patient survival, recovery, and long-term quality of life.

Advanced Technology & Facilities

• Cell Therapy Centers: CAR-T cell production facilities and advanced stem cell labs
• Hematology Units: Modern bone marrow transplant centers with sterile isolation wards
• Oncology Care Systems: Precision radiotherapy units, image-guided therapy machines, and advanced chemotherapy stations
• Diagnostic Tools: Genomic sequencing platforms, molecular diagnostics, and high-end imaging for cancer detection
• Research Integration: Academic Research Organization model combining clinical studies, translational medicine, and basic research
• Hospital Network: Seven hospitals with nearly 1,500 beds across Beijing, Shanghai, and Guangzhou

Key Services

• Hematology Treatments: Leukemia, lymphoma, multiple myeloma, and thalassemia management with stem cell transplantation and CAR-T therapy
• Oncology Care: Comprehensive treatment for gastrointestinal, lung, liver, sarcoma, and breast cancers using surgery, radiotherapy, and targeted drugs
• Cell Therapy: Advanced CAR-T immunotherapy for blood cancers and ongoing research for solid tumors
• Multidisciplinary Approach: Teams of hematologists, oncologists, surgeons, and researchers create individualized care plans
• Pediatric Hematology: Specialized services for children with congenital blood disorders and cancers
• International Patient Services: Multilingual support, visa assistance, accommodation, and personalized recovery planning for global patients